Before evaluating the predictive value of miR-185 in DCM development, we had compared the clinical data between miR-185high and miR-185low patients at baseline, and the only difference was the anti-β1-AR antibody content of the blood. The gene discussed is ADRB1; the disease is familial dilated cardiomyopathy.